JJBC
MREO

James J. Burns & Company’s Mereo BioPharma MREO Stock Holding History

James J. Burns & Company’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.3K Buy
+95,400
New +$28.6K ﹤0.01% 162

Other funds holding MREO

TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JF
JMN Financial New Albany, Ohio $129M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SWP
Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return

James J. Burns & Company's MREO Position: Q2 2026 in Review

James J. Burns & Company opened a new position in Mereo BioPharma (MREO) in Q2 2026: 95,400 shares worth $30.3K. The stake represents ﹤0.01% of the portfolio and ranks #162 among its holdings.

25 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

  • James J. Burns & Company held 95,400 shares of Mereo BioPharma worth $30.3K as of Q2 2026.
  • Mereo BioPharma was a new James J. Burns & Company position in Q2 2026.
  • Mereo BioPharma made up ﹤0.01% of James J. Burns & Company's portfolio in Q2 2026, its #162 holding.
  • 25 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on James J. Burns & Company's 13F filing for Q2 2026, filed 6 Aug 2026.